Related Experiment Video
Updated: Jul 19, 2026
05:36
Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Vaccines in renal cell carcinoma
Hubert Kübler1, Johannes Vieweg
1Department of Urology, University of Florida, College of Medicine, Gainesville, FL 32610-0247, USA.
Seminars in Oncology
|October 19, 2006
Summary
Cancer vaccines show promise for treating advanced renal cell carcinoma (RCC) by boosting T cells to fight tumors and prevent recurrence. Future research aims to improve vaccine effectiveness and accessibility for more patients.
Area of Science:
- Oncology
- Immunology
- Cancer Therapy
Background:
- Significant advancements in understanding renal cell carcinoma (RCC) molecular and cellular pathways.
- Improved prospects for altering tumor progression and metastatic potential of renal neoplasms.
Purpose of the Study:
- Review the current status of vaccine-based therapy for advanced RCC.
- Discuss mechanisms of action for cancer vaccines in RCC.
- Provide information on relevant clinical trials and future applications.
Main Methods:
- Literature review of vaccine strategies for advanced renal cell carcinoma.
- Analysis of clinical trial data and preclinical research.
- Exploration of mechanisms of action for active specific immunotherapy.
Main Results:
- Cancer vaccination is a promising active specific immunotherapy approach for RCC.
- Vaccines aim to expand tumor-eradicating T cells and induce memory T cells.
- Several vaccine strategies have progressed to clinical investigation.
Conclusions:
- Vaccine-based therapies offer a potential strategy for managing advanced RCC.
- Future research focuses on enhancing T-cell responses and broadening patient applicability.
- Continued investigation is crucial for optimizing cancer vaccine efficacy in RCC treatment.
More Related Videos
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...